Prion-like aggregates: Infectious agents in human disease

Trends in Molecular Medicine

Volumn 16, Issue 11, 2010, Pages 501-507

  Westermark, Gunilla T ^a   Westermark, Per ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN;

AMYLOIDOSIS; CREUTZFELDT JAKOB DISEASE; HUMAN; NONHUMAN; PRION; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN FOLDING; REVIEW; VIRUS INFECTION;

AMYLOID; AMYLOIDOSIS; ANIMALS; HUMANS; MICE; MUTATION; PREALBUMIN; PRION DISEASES; PRIONS; PROTEIN FOLDING;

ANIMALIA; MURINAE;

EID: 78049285236     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.08.004     Document Type: Review

References (62)

1. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216:136-144.
2. Hurshman A.R., et al. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 2004, 43:7365-7381.
3. Knowles T.P.J., et al. An analytical solution to the kinetics of breakable filament assembly. Science 2009, 326:1533-1537.
4. Westermark P., et al. A primer of amyloid nomenclature. Amyloid 2007, 14:179-183.
5. Kayed R., et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
6. Lord A., et al. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease. Neurobiol. Dis. 2009, 36:425-434.
7. Jarrett J.T., Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimerós disease and scrapie?. Cell 1993, 73:1055-1058.
8. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 1999, 265:501-523.
9. Tam S.P., et al. Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. J. Lipid Res. 2002, 43:1410-1420.
10. van der Westhuyzen D.R., et al. HDL cholesterol transport during inflammation. Curr. Opin. Lipidol. 2007, 18:147-151.
11. Booth D.R., et al. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998, 5:262-265.
12. Ranlov P. The adoptive transfer of experimental mouse amyloidosis by intravenous injections of spleen cell extracts from casein-treated syngeneic donor mice. Acta Path. Microbiol. Scand. 1967, 70:321-335.
13. Kisilevsky R. Preparation and propagation of amyloid-enhancing factor. Methods Mol. Biol. 2005, 299:237-241.
14. Lundmark K., et al. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6979-6984.
15. Johan K., et al. Acceleration of AA-amyloidosis by amyloid-like synthetic fibrils. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2558-2563.
16. Sørby R., et al. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Amyloid 2008, 15:20-28.
17. Zhang B., et al. Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7263-7268.
18. Fox G.A., et al. Health of herring gulls (Larus argentatus) in relation to breeding location in the early 1990s. II. Cellular and histopathological measures. J. Toxicol. Environ. Health A. 2007, 70:1471-1491.
19. Hampel M.R., et al. Increasing fatal AA amyloidosis in hunting falcons and how to identify the risk: a report from the United Arab Emirates. Amyloid 2009, 16:122-132.
20. Fu X., et al. Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett. 2004, 563:179-184.
21. Qian J., et al. Mouse senile amyloid fibrils deposited in skeletal muscle exhibit amyloidosis-enhancing activity. PLoS Pathog. 2010, 6:e1000914.
22. Sponarova J., et al. AA-amyloidosis can be transferred by peripheral blood monocytes. PLoS ONE 2008, 3:e3308.
23. Gajdusek D.C. Kuru and its contribution to medicine. Phil. Trans. R. Soc. B 2008, 363:3697-3700.
24. Westermark P., Westermark G.T. Reflections on amyloidosis in Papua New Guinea. Phil. Trans. R. Soc. B 2008, 363:3701-3705.
25. Llewelyn C.A., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004, 363:417-421.
26. Brown P., et al. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006, 67:389-393.
27. Eisele Y.S., et al. Induction of cerebral β-amyloidosis: intracerebral versus systemic Aβ inoculation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12926-12931.
28. Krebs M.R.H., et al. Observation of sequence specificity in the seeding of protein fibrils. Protein Sci. 2004, 13:1933-1938.
29. Wiltzius J.J., et al. Molecular mechanisms for protein-encoded inheritance. Nat. Struct. Mol. Biol. 2009, 16:973-978.
30. O'Nuallian B., et al. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 2004, 279:17490-17499.
31. Cui D., et al. Acceleration of murine AA amyloid deposition by bovine fibrils and tissue homogenates. Amyloid 2008, 15:77-83.
32. Horiuchi N., et al. Experimental induction of amyloidosis by bovine amyloid fibrils in Sore Hock rabbits. Amyloid 2008, 15:84-88.
33. Tojo K., et al. Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid 2005, 12:103-108.
34. Solomon A., et al. Amyloidogenic potential of foie gras. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10998-11001.
35. Sekijima Y., et al. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr. Pharm. Des. 2008, 14:3219-3230.
36. Gajdusek D.C. Infectious amyloids: Subacute spongiform encephalopathies as transmissible cerebral amyloidoses. Fields Virology 1996, 2851-2900. Lippincott-Raven. 3rd edn. B.N. Fields (Ed.).
37. Suhr O.B., et al. Early liver transplantation improves familial amyloidotic polyneuropathy patients' survival. Amyloid 2005, 12:233-238.
38. Yamamoto S., et al. Long-term consequences of domino liver transplantation using familial amyloidotic polyneuropathy grafts. Transpl. Int. 2007, 20:926-933.
39. Stangou A.J., et al. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N. Engl. J. Med. 2005, 352:2356.
40. Tagoe C.E., et al. Amyloidogenesis is neither accelerated nor enhanced by injections of preformed fibrils in mice transgenic for wild-type human transthyretin: the question of infectivity. Amyloid 2004, 11:21-26.
41. Colby D.W., et al. Design and construction of diverse mammalian prion strains. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20417-20422.
42. Makarava N., Baskakov I.V. The same primary structure of the prion protein yields two distinct self-propagating states. J. Biol. Chem. 2008, 283:15988-15996.
43. Makarava N., et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropat. 2010, 119:177-187.
44. Li J., et al. Darwinian evolution of prions in cell culture. Science 2010, 327:869-872.
45. Petkova A.T., et al. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 2005, 307:262-265.
46. Meyer-Luehmann M., et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006, 313:1781-1784.
47. Bergström J., et al. Two different types of amyloid deposits - apolipoprotein A-IV and transthyretin - in a patient with systemic amyloidosis. Lab. Invest. 2004, 84:981-988.
48. Ihse E., et al. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J. Path. 2008, 216:253-261.
49. Lutz T.A. The role of amylin in the control of energy homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R1475-1484.
50. Kahn S.E., et al. Islet amyloid. A long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 1999, 48:241-253.
51. Westermark P. Quantitative studies of amyloid in the islets of Langerhans. Upsala J. Med. Sci. 1972, 77:91-94.
52. Kordower J.H., et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 2008, 14:504-506.
53. Hawkes C.H., et al. A timeline for Parkinson's disease. Parkinsonism Relat. Disord. 2010, 16:79-84.
54. Raposo G., et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183:1161-1172.
55. Gousset K., et al. Prions hijack tunnelling nanotubes for intercellular spread. Nat. Cell Biol. 2009, 11:328-336.
56. Paulsson J.F., et al. Intracellular amyloid-like deposits contain unprocessed pro islet amyloid polypeptide (proIAPP) in beta-cells of transgenic mice overexpressing human IAPP and transplanted human islets. Diabetologia 2006, 49:1237-1246.
57. Oskarsson M.E., Westermark G.T. Transfer of IAPP amyloid between murine beta cells. Amyloid 2010, 17(Suppl. 1):96.
58. Westermark G.T., Paulsson J.F. Seeding of pancreatic islet amyloid. Amyloid 2006, 13(Suppl. 1):68.
59. de Groot N.S., et al. Amyloids in bacterial inclusion bodies. Trends Biochem. Sci. 2009, 34:408-416.
60. Lundmark K., et al. Protein fibrils in nature can enhance AA amyloidosis in mice: cross-seeding as a disease mechanism. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6098-6102.
61. Ellis-Behnke R.G., et al. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5054-5059.
62. Westermark P., et al. Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model. PLoS ONE 2009, 4:e6041.